Role of interleukins and nitric oxide secretion by peritoneal macrophages in differential tumoricidal effect to transplantable melanomas as regarding their biological properties

Immunopharmacology and Immunotoxicology

Volumn 28, Issue 2, 2006, Pages 305-317

  Kozlowska K ^a   Cichorek, M ^a   Wachulska, M ^a   Bautembach, I ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Interleukin 12; Interleukin 18; Nitric Oxide; Peritoneal Macrophages; Transplantable Melanoma

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 18; NITRIC OXIDE;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; HAMSTER; INNATE IMMUNITY; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MALE; MELANOMA; MELANOSIS; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; CELL LINE, TUMOR; CRICETINAE; CRICETULUS; INTERLEUKINS; MACROPHAGES, PERITONEAL; MALE; MELANOMA; NEOPLASM TRANSPLANTATION; NITRIC OXIDE;

ANIMALIA; CRICETINAE;

EID: 33746819783     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970600809413     Document Type: Article

References (39)

1. Nakamura, K.; Okamura, H.; Wada, M.; Nagata, K.; Tamura, T. Endotoxin-induced serum factor that stimulates gamma interferon production. Infect. Immun. 1989, 57(2), 590-595.
2. Okamura, H.; Kashiwamura, S.; Tsutsui, H.; Yoshimoto, T.; Nakanishi, K. Regulation of interferon-gamma production by IL-12 and IL-18. Curr. Opin. Immunol. 1998, 10(3), 259-264.
3. Vida l-Vanaclocha, F.; Fantuzzi, G.; Mendoza, L.; Fuentes, A.M.; Anasagasti, M.J.; Martin, J.; Carrascal, T.; Walsh, P.; Reznikov, L.L.; Kim, S.H.; Novick, D.; Rubinstein, M.; Dinarello, C.A. IL-18 regulates IL-1β-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc. Natl. Acad. Sci. USA 2000, 97(2), 734-739.
4. Bomirski, A.; Dominiczak, T.; Nowińska, L. Spontaneous transplantable melanoma in golden hamster. Acta Union Int. Cancer 1962, 18, 178-180.
5. Hashimoto, W.; Osaki, T.; Okamura, H.; Robbins, P.D.; Kurimoto, M.; Nagata, S.; Lotze, M.T.; Tahara, H. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand-and-perforin-induced tumor apoptosis, respectively. J. Immunol. 1999, 163(2), 583-589.
6. Nagai, H.; Hara, I.; Horikawa, T.; Fujii, M.; Kurimoto, M.; Kamidono, S.; Ichihashi, M. Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18. Cancer Invest. 2000, 18(3), 206-213.
7. Osaki, T.; Hashimoto, W.; Gambotto, A.; Okamura, H.; Robinns, P.D.; Kurimoto, M.; Lotze, M.T.; Tahara, H. Potent antitumor effects mediated by local expression of the mature form of the interferon-γ inducing factor, interleukin-18 (IL-18). Gene Ther. 1999, 6(5), 808-815.
8. Yamamoto, Y.; Kato, Z.; Matsukuma E., Li, A.; Omoya, K.; Hashimoto, K.; Ohnishi, H.; Kondo, N. Generation of highly stable IL-18 based on a ligand-receptor complex structure. Biochem. Biophys. Res. Commun. 2004, 317(1), 181-186.
9. Coughlin, C.M.; Wysocka, M.; Trinchien, G.; Lee, W.M. The effect of interleukin 12 desensitization on the antitumor efficacy of recombinant interleukin 12. Cancer Res. 1997, 57(12), 2460-2467.
10. Coughlin, C.M.; Salhany, K.E.; Wysocka, M.; Aruga, E.; Kurzawa, H.; Chang, A.E.; Hunter, C.A.; Fox, J.C.; Trinchieri, G.; Lee, W.M. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J. Clin. Invest. 1998, 101(6), 1441-1452.
11. Lebel-Binay, S.; Berger, A.; Zinzindohoue, F.; Ugnenc, P.H.; Thiounn, N.; Fridman, W.H.; Pages, F. Interleukin-18: biological properties and clinical implications. Eur. Cytokine Netw. 2000, 11(1), 15-26.
12. Wang, Q.; Yu, H.; Zhang, L.; Ju, D.; Pan, J.; Xia, D.; He, L.; Wang, J.; Cao, X. Vaccination with IL-18 gene-modified, superantigen-coated tumor cells elicits potent antitumor immune response. J. Cancer Res. Clin. Oncol. 2001, 127(12), 718-726.
13. Carrascal, M.T.; Mendoza, L.; Valcarcel, M.; Salado, C.; Egilegor, E.; Telleria, N.; Vidal-Vanaclocha, F.; Dinarello, C.A. Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium. Cancer Res. 2003, 63(2), 491-497.
14. Park, H.; Byun, D.; Kim, T.S.; Kim, Y.S.; Kang, J.I.; Hahm, E.S.; Kim, S.H.; Lee, W.J.; Song, H.K.; Yoon, D.Y.; Kang, C.J.; Lee, C.; Honh, D.; Kim, H.; Cho, B., Kim, Y.; Yang, Y.H.; Min, K.A.; Cho, D.H. Enhanced IL-18 expression in common skin tumors. Immunol. Lett. 2001, 79(3), 215-219.
15. Cavallo, F.; Signorelli, P.; Mirella, G.; Musiani, P.; Modesti, A.; Brunda, M.J.; Colombo, M.P.; Forni, G. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J. Natl. Cancer Inst. 1997, 89(14), 1049-1058.
16. Chen, L.; Chen, D.; Block, E.; O'Donnell, M.; Kufe, D.W.; Clinton, S.K. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. J. Immunol 1997, 159(1), 351-359.
17. Tahara, H.; Zeh, H.J.; Storkus, W.J.; Pappo, I.; Watkins, S.C.; Gubler, U.; Wolf, S.F.; Robbins, P.D.; Lotze, M.T. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. Cancer Res. 1994, 54(1), 182-189.
18. Tahara, H.; Lotze, M.T. Antitumor effects of interleukin-12 (IL-12): applications for the immunotherapy and gene therapy of cancer. Gene Ther. 1995, 2(2), 96-106.
19. Li, J.; Billiar, T.R.; Talanian, R.V.; Kim, Y.M. Nitric Oxide reversibly inhibits seven members of the caspase family via S-nitrosylation. Biochem. Biophys. Res. Commun. 1997, 240(2), 419-424.
20. Kozłowska, K.; Cichorek, M.; Zarzeczna, M. Influence of transplantable melanomas on the secretion of cytokines by hamster peritoneal macrophages. Arch. Immunol. Ther. Exp. 1999, 47(6), 361-365.
21. Kito, T.; Kuroda, E.; Yokota, A.; Yamashita, U. Cytotoxicity in glioma cells due to interleukin-12 and interleukin-18 stimulated macrophages mediated by interferon-gamma-regulated nitric oxide. J. Neurosurg. 2003, 98(2), 385-392.
22. Matsuura, M.; Saita, S.; Hirai, Y.; Okamura, H. A pathway trough interferon-γ is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells. Eur. J. Biochem. 2003, 270(19), 4016-4025.
23. Kozłowska, K.; Żurawska-Czupa, B.; Mierzewski, P.; Kostulak, A. Use of macrophages migration inhibition test to evaluate antigenic differences in golden hamster transplantable melanomas. Int. J. Cancer 1980, 26(2), 211-215.
24. Kozłowska, K.; Cichorek, M.; Zarzeczna, M. Implication of macrophage NO and cytokine secretion in the cytotoxicity of transplantable melanomas as regards the progression of these tumors. Int. J. Immunopathol. Pharmacol. 2000, 13(2), 69-76.
25. Bomirski, A. Biological properties of transplantable melanomas in the Syrian hamster during 16 years of maintenance by several passages. Medical Academy, Gdańsk 1977.
26. Kozłowska, K.; Żurawska-Czupa, B.; Kostulak, A. Comparison of the antigenecity of melanotic and amelanotic melanoma cells after the release of surface glycoproteins by trypsin. Arch. Immunol. Ther. Exp. 1980, 28(4), 641-644.
27. Bomirski, A; Kozłowska, K; Żurawska-Czupa, B. An attempt to prepare nonenzymatically a single cell suspension from solid transplantable melanomas. Abstract, 9th Int. Pigment Cell Conference TX, Houston, 1975; 5-6.
28. Żurawska-Czupa, B.; Kozłlowska, K. A simple method for obtaining pure fraction of hamster peritoneal macrophages. Arch. Immunol. Ther. Exp. 1978, 26(1-6), 441-443.
29. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5289), 680-685.
30. Ding, A.H.; Nathan, C.F.; Stuehr, D.J. Release of reactive nitrogen intermediates and reactive oxygen. J. Immunol. 1988, 141(7), 2407-2412.
31. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Meth. 1983, 65(1-2), 55-63.
32. 1. J. Immunol. 2002, 168(5), 2282-2287.
33. Cho, D.; Song, H.; Kim, Y.M.; Houh, D.; Hur, B.Y.; Park, H.; Yoon, D.; Pyun, K.H.; Lee, W.J.; Kurimoto, M.; Kim, Y.B.; Kim, Y.S.; Choi, I. Endogenous interleukin-18 modulates immune escape of murine melanoma cells by regulating the expression of Fas ligand and reactive oxygen intermediates. Cancer Res. 2000, 60(10), 2703-2709.
34. Nakamura, S.; Otani, T.; Ijiri, Y.; Motoda, R.; Kurimoto, M.; Orita, K. IFN-γ-dependent and-independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12. J. Immunol. 2000, 164(6), 3330-3336.
35. Zhang, T.; Kawakami, K.; Qershui, M.H.; Okamura, H.; Kurimoto, M.; Saito, A. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of the murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 1997, 65(9), 3594-3599.
36. Abbas, A.; Lichtman, A. Cellular and Medical Immunology; Saunders: Philadelphia, 2003; 243-274.
37. Snijders, A.; Hilkens, C.M.; van der Pouwkraan, T.C.; Engel, M.; Aarden, L.A.; Kapsenberg, M.L. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by expression of the p53 subunit. J. Immunol. 1996, 156(3), 1207-1212.
38. Hayes, M.P.; Wang, J.; Norcross, M.A. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-γ of lipopolysaccharide-inducible p53 and p40 genes. Blood 1995, 86(2), 646-650.
39. Kim, Y.M.; Talanian, R.V.; LI, J.; Billiar, T.R. Nitric oxide prevents IL-1beta and IFN-gamma-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1beta-converting enzyme). J. Immunol. 1998, 161(8), 4122-4128.